These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6745736)

  • 21. Advantages and disadvantages of low-dose oral contraceptives.
    Law B
    Int J Gynaecol Obstet; 1978-1979; 16(6):556-60. PubMed ID: 39826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncontraceptive uses of the pill.
    Halbert DR
    Clin Obstet Gynecol; 1981 Sep; 24(3):987-93. PubMed ID: 6456856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives.
    Davis AR; Westhoff CL
    J Pediatr Adolesc Gynecol; 2001 Feb; 14(1):3-8. PubMed ID: 11358700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.
    de Melo NR
    Womens Health (Lond); 2010 Sep; 6(5):721-35. PubMed ID: 21080791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial.
    Harada T; Momoeda M; Terakawa N; Taketani Y; Hoshiai H
    Fertil Steril; 2011 May; 95(6):1928-31. PubMed ID: 21420678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dysmenorrhea].
    Bråkenhielm A; Asplund J
    Lakartidningen; 1980 Mar; 77(12):1100-1. PubMed ID: 7374258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysfunctional uterine bleeding and dysmenorrhea.
    Coll Capdevila C
    Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):229-37. PubMed ID: 9678078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic uses of contraceptive steroids.
    Starks GC
    J Fam Pract; 1984 Sep; 19(3):315-21. PubMed ID: 6470632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of body composition during low-dose estrogen oral contraceptives treatment.
    Franchini M; Caruso C; Nigrelli S; Poggiali C
    Acta Eur Fertil; 1995; 26(2):69-73. PubMed ID: 9098463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
    Ekström P; Juchnicka E; Laudanski T; Akerlund M
    Contraception; 1989 Jul; 40(1):39-47. PubMed ID: 2505970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysmenorrhea in adolescents.
    Harel Z
    Ann N Y Acad Sci; 2008; 1135():185-95. PubMed ID: 18574224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potencies of oral contraceptives.
    Edgren RA; Sturtevant FM
    Am J Obstet Gynecol; 1976 Aug; 125(8):1029-38. PubMed ID: 952300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives and endometriosis.
    Karnacky KJ
    Am J Obstet Gynecol; 1979 Sep; 135(2):279-80. PubMed ID: 474682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
    Vaidya RA; Shringi MS; Vaidya AB; Gogate JG
    J Assoc Physicians India; 1997 Nov; 45(11):883-4. PubMed ID: 11229194
    [No Abstract]   [Full Text] [Related]  

  • 39. Which pill to choose if breastfeeding.
    Fam Plann Inf Serv; 1978 Feb; 1(1):17. PubMed ID: 12308931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study.
    Lindh I; Milsom I
    Hum Reprod; 2013 Jul; 28(7):1953-60. PubMed ID: 23578948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.